Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from OGN

3 Cheap Small-Cap Stocks to Scoop Up on the Market Pullback

With small-cap stocks grabbing investors' attention lately, here are three discounted names with solid fundamentals to grab now, while the retracement provides a prime entry point.

Barchart

3 Value Stocks With Dividend Yields Above 4%

Value stocks tend to perform well during economic recoveries and periods of market volatility, making them a good option for long-term investors seeking stability and growth. Additionally, these stocks often pay dividends, offering an additional income stream. Hence, fundamentally solid value stocks Enterprise Products (EPD), Energy Transfer (ET), and Organon…

StockNews.com

Top 4 Pharma Stocks for Long-Term Value Investors in 2024

The pharmaceutical sector is experiencing rapid growth thanks to the rising demand for precision drugs, the growing geriatric population, and an uptick in chronic diseases. Given this backdrop, long-term value investors could consider buying and holding quality pharmaceutical stocks such as Organon (OGN), Procaps (PROC), Johnson & Johnson (JNJ), and…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Pharma Stocks to Watch in 2024 for Later Gains

The pharmaceutical industry looks well-positioned for long-term growth. Hence, pharma stocks Procaps Group (PROC), Organon (OGN) and Amphastar (AMPH) might be ideal additions to your watchlists for later gains. Read on.

StockNews.com

Are These 3 Pharma Stocks a Buy or Hold Opportunity for December?

The pharmaceutical industry looks well-positioned for long-term growth. So, let us analyze pharma stocks Procaps Group (PROC), Voyager Therapeutics (VYGR) and Organon & Co. (OGN) to identify whether they are a Buy or Hold. Read on.

StockNews.com

Under $15 Bargains: 3 Pharma Stocks to Watch

The pharmaceutical industry is anticipated to remain resilient, owing to increasing healthcare expenditure. Given this backdrop, it could be wise to watch quality pharma stocks Organon & Co. (OGN), GoodRx Holdings (GDRX), and Viatris (VTRS) trading under $15 now. Read on….

StockNews.com

3 Pharma Stocks Ready to Shine This Week

The pharmaceutical industry is expected to thrive, driven by the increasing need for chronic disease management and the requirements of an aging demographic. Given the industry’s solid prospects, quality pharma stocks Organon (OGN), GoodRx Holdings (GDRX), and Collegium Pharmaceutical (COLL) could be solid buys this week. Read on….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Top 3 Pharma Stocks With Promising Prospects for October

The pharmaceutical sector is expected to grow rapidly in the coming years, owing to rising worldwide medical needs. Given the industry’s solid prospects, investors could consider buying quality pharma stocks such as Eagle Pharmaceuticals (EGRX), Organon (OGN), and Collegium Pharmaceutical (COLL) this month. Read on.

StockNews.com

"X-Men meets Attack on Titan" in West African mythology inspired OGN The Asiri

YouNeek Studios returns to Dark Horse for The Asiri Vol. 1, a new sci-fi/fantasy superhero story

GamesRadar

A simple device could prevent thousands of maternal deaths. Why did it take so long to get to market?

Alydia Health's Jada system for postpartum hemorrhage took 11 years to reach the market; being a women's health product made its road tougher.

Fortune

Victoria's Secret Among Bank of America Diversity-Stock Picks

'Several diversity, equity, and inclusion demographic factors already impact the global economy,' Bank of America analysts say.

The Street

3 Red-Hot Healthcare Stocks Ignoring the Market's Downtrend

Despite bearish market sentiment, the healthcare industry has outperformed the broader market thanks to its defensive nature. Given overwhelming demand and the need for global healthcare development, we think the stocks of quality healthcare companies Cigna (CI), Organon (OGN), and Bristol-Myers Squibb (BMY) could be solid bets now. These stocks…

StockNews.com

Organon Easily Beats First-Quarter Expectations Despite Nexplanon Slip-Up

Organon easily beat first-quarter expectations Thursday despite a dive for its flagship product, Nexplanon, and OGN stock popped.

Investors Business Daily

Organon Pares Early Losses, Climbing On Massive Nexplanon Demand

Organon offered a light 2022 sales outlook on Thursday, but OGN stock recovered from an early dip following the company's beat.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Established Brands Hit Organon's Q4 Sales, Expects FY22 Sales Of Upto $6.4B

Organon & Co's (NYSE: OGN)

StockNews.com

3 Recent IPOs That Wall Street Predicts Will Rally 33% or More

Last year proved to be a record-breaking year for IPOs, amid government stimulus and soaring valuations. However, this year, the market is under pressure because of the looming interest rate hikes. Though the market could remain under pressure in the upcoming months, Wall Street analysts expect recent IPOs Organon (OGN),…

People

Sristi Suman JayaswalThe

216 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medical Pharmaceuticals

113 stories

110 stories

BristolMyers Squibb Company

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.